Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enhancing HCP Education in Adult Vaccination against Respiratory Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland
    Migraine and Women’s Health
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement, Research Internal Medicine USA
    Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Prostate Cancer: Best Practices for Combining Targeted Therapies in mPC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Enhancing HCP Education in Maternal Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Saudi Arabia
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Rare Disease Canada
    Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Italy
    Projects for Enhancing Regional Cancer Treatment
    Release Date:
    Partner: Japanese Society of Clinical Oncology
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Oncology Japan
    Sickle Cell Disease (SCD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Cancer Registry
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Oncology Congo, The Democratic Republic
    The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Improving the Therapeutic Environment for Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Shared Decision-Making (SDM) in Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA